Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Genprex Inc (NQ: GNPX ) 2.150 -0.100 (-4.44%) Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Genprex Inc < Previous 1 2 3 4 5 6 7 Next > Genprex Inc. (NASDAQ: GNPX) Announces Positive Data From Phase 1 Clinical Trial Evaluating REQORSA(R) Immunogene Therapy for Late-Stage Non-Small Cell Lung Cancer June 14, 2023 Via Investor Brand Network InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Chief Medical Officer Featured Guest on Latest Bell2Bell Release June 08, 2023 Via Investor Brand Network BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Eyes Broad-Based Application Potential of ONCOPREX(R) Nanoparticle Delivery System June 07, 2023 Via Investor Brand Network Genprex Inc.’s (NASDAQ: GNPX) Inspiring Patient Video on Gene Therapy’s Potential in NSCLC Treatment June 02, 2023 Via Investor Brand Network InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Releases Video Featuring Clinical Trial Patient Sharing Study Experience June 02, 2023 Via Investor Brand Network Genprex (NASDAQ:GNPX) Releases New Patient Video Interview Describing Positive Experience In Clinical Trial June 02, 2023 Via ACCESSWIRE Genprex (NASDAQ: GNPX) Releases New Patient Video Interview Describing Positive Experience in Clinical Trial June 01, 2023 A clinical-stage gene therapy company is making splashes in the medical world. Genprex, Inc. (NASDAQ: GNPX) is developing potentially life-changing therapies for patients with cancer and diabetes that... Via Benzinga InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Receives SRC Approval to Advance to Phase 2 Portion of REQORSA(R) Clinical Trial May 30, 2023 Via Investor Brand Network InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces Results of Phase 1 Clinical Trial Will Be Published at ASCO Meeting May 26, 2023 Via Investor Brand Network InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces New Video Featuring Chief Medical Officer Discussing Positive Preclinical Data with NPRL2 Gene Therapy May 23, 2023 Via Investor Brand Network Genprex Inc. (NASDAQ: GNPX) Research Collaborators Present Positive Preclinical Data at American Association of Cancer Research 2023 Annual Meeting May 17, 2023 Via Investor Brand Network InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) to Participate and Present at Upcoming May Industry and Investor Conferences May 08, 2023 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Crude Oil Up 1.5%; Philips Shares Jump After Q1 Results April 24, 2023 U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping around 40 points on Monday. The Dow traded up 0.05% to 33,827.42 while the NASDAQ fell 0.33% to 12,032.16.... Via Benzinga Why IDEAYA Biosciences Shares Are Trading Higher By Around 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session April 24, 2023 Gainers Aclarion, Inc. (NASDAQ: ACON) shares surged 152% to $1.85 amid the publication of durability data for the company's back pain treatment. Via Benzinga US Stocks Turn Lower; Nasdaq Dips 100 Points April 24, 2023 U.S. stocks turned lower midway through trading, with the Nasdaq Composite dropping around 100 points on Monday. The Dow traded down 0.19% to 33,744.92 while the NASDAQ fell 0.84% to 11,971. The S&P... Via Benzinga InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces Positive Data Supporting Therapeutic Potential of Its Non-Viral Delivery System April 19, 2023 Via Investor Brand Network Genprex Touts Encouraging Preclinical Data From Lung Cancer Candidate April 19, 2023 Genprex Inc (NASDAQ: GNPX) announced that its research collaborators presented preclinical data for the NPRL2 gene (also known as the TUSC4 gene). Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session April 19, 2023 Via Benzinga Why Sonnet BioTherapeutics Shares Are Trading Lower By Around 13%; Here Are 20 Stocks Moving Premarket April 19, 2023 Gainers Clearmind Medicine Inc. (NASDAQ: CMND) jumped 69.3% to $0.8480 in pre-market trading after dropping 12% on Tuesday. Clearmind Medicine recently announced a $3.5 million public offering priced... Via Benzinga InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces Positive Research Findings, Additional Support for REQORSA(R) and Its Therapeutic Potential April 18, 2023 Via Investor Brand Network Cancer And Diabetes Remain Among The Deadliest And Most Debilitating Diseases — Is Gene Therapy The Solution? One Company, Genprex, Inc. (NASDAQ: GNPX), Thinks So April 18, 2023 On their own, cancer or diabetes can be debilitating and deadly. The two are common diseases with tremendous impact on health worldwide. Via Benzinga InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Provides Statement Regarding FDA Initiative to Accelerate Approval Process for Gene Therapies March 23, 2023 Via Investor Brand Network Exposures Product Safety InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) to Present at Upcoming Barcelona Conference March 13, 2023 Via Investor Brand Network Genprex’s Gene Therapy: Potential Breakthrough for Diabetes and Lung Cancer March 09, 2023 Genprex’s Gene Therapy: Potential Breakthrough for Diabetes and Lung Cancer Via News Direct InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Management to Participate in Two Upcoming Conferences March 08, 2023 Via Investor Brand Network S&P 500 Rises Over 0.5%; US Pending Home Sales Increase Sharply February 27, 2023 U.S. stocks traded higher toward the end of trading, with the NASDAQ Composite gaining around 100 points on Monday. The Dow traded up 0.40% to 32,949.23 while the NASDAQ rose 0.93% to 11,500.59. The... Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session February 27, 2023 Via Benzinga Nasdaq Rises 80 Points; TEGNA Shares Plunge February 27, 2023 U.S. stocks traded higher midway through trading, with the NASDAQ Composite gaining around 80 points on Monday. The Dow traded up 0.15% to 32,867.61 while the NASDAQ rose 0.70% to 11,475.20. The S&P... Via Benzinga Why Smith Micro Software Shares Are Trading Lower By Over 46%? Here Are Other Stocks Moving In Monday's Mid-Day Session February 27, 2023 Gainers Lucira Health, Inc. (NASDAQ: LHDX) jumped 354% to $0.6369 after the company announced FDA authorization for its at-home combination COVID-19 & flu test. Via Benzinga InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces $4M Registered Direct Offering February 27, 2023 Via Investor Brand Network < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
